ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 257

Alcohol Use Hospitalizations in People with Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain Are Increasing: A Time-trends Study Using the U.S. National Data

Jasvinder Singh1 and john Cleveland 2, 1University of Alabama Medical Center, Birmingham, 2University of Alabama at Birmingham, Birmingham, AL

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: alcohol use, fibromyalgia and rheumatoid arthritis (RA), gout, Health Care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Alcohol abuse and associated mortality is an important public health problem in the U.S. To our knowledge, limited data are available on alcohol use disorder-related hospitalizations in people with common musculoskeletal diseases.

Methods: We used the U.S. National Inpatient Sample (NIS) data from 1998-2014 to examine the rates of alcohol use disorder-related hospitalizations without overdose, detoxification or rehabilitation services, based on the presence of International Classification of Diseases, Ninth or Tenth Revision, Clinical Modification (ICD-9-CM or ICD-10-CM) diagnostic codes for alcohol dependence or abuse in the primary diagnosis position. We assessed five common rheumatic diseases using the respective diagnostic codes in a secondary position: Gout, rheumatoid arthritis (RA), fibromyalgia, osteoarthritis (OA), and low back pain (LBP). Incidence of alcohol use disorder claims was assessed per 100K NIS claims overall.

Results: The incidence of alcohol use disorder-related primary hospitalizations was low in 1998-2000 for the five musculoskeletal conditions and increased over the 19-year study period (Table1). The increase was 2-fold higher in people with gout, osteoarthritis or LBP,  2.5-fold for RA versus 3-fold higher in people with fibromyalgia. Rates of alcohol use disorder per 100K total NIS claims showed similar trends, with an increase ranging 3-fold in people with gout, osteoarthritis, LBP or RA to 4.5-fold in people with fibromyalgia (Table 2).  There was a plateauing of alcohol use disorder claims for all conditions except osteoarthritis (Figure 1).

Conclusion: The rate of increase in alcohol use disorder hospitalizations occurred in all 5 musculoskeletal conditions, but the rate differed by the condition. Providers need to counsel their patients with these musculoskeletal conditions regarding the risk and impact of alcohol use, in order to prevent associated morbidity and mortality. Findings are also important for policy makers with regards to resource allocation.


Table1_Alcohol

Table 1. Number of alcohol use disorder as the primary reason for hospitalizations from 1998 to 2016 by five common musculoskeletal diseases


Table2_Alcohol

Table 2. Rate of alcohol use disorder primary hospitalizations from 1998 to 2016 per 100k total NIS claims by five common musculoskeletal diseases


Fig1_Alcohol

Figure 1. Trends in rates of primary alcohol abuse claims per 100K NIS claims, by five musculoskeletal conditions


Disclosure: J. Singh, Amarin pharmaceuticals, 1, 4, Clearview healthcae partners, 5, Clearview healthcare partners, 5, Clinical Care options, 5, Horizon, 5, Medisys, 5, OMERACT, 6, Putnam associates, 5, Spherix, 5, the American College of Rheumatology, 5, The American College of Rheumatology, 5, The National Institues of Health, 5, the National Institutes of Health, 5, Viking therapeutics, 1, 4, WebMD, 5; j. Cleveland, None.

To cite this abstract in AMA style:

Singh J, Cleveland j. Alcohol Use Hospitalizations in People with Gout, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia, and Low Back Pain Are Increasing: A Time-trends Study Using the U.S. National Data [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/alcohol-use-hospitalizations-in-people-with-gout-osteoarthritis-rheumatoid-arthritis-fibromyalgia-and-low-back-pain-are-increasing-a-time-trends-study-using-the-u-s-national-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/alcohol-use-hospitalizations-in-people-with-gout-osteoarthritis-rheumatoid-arthritis-fibromyalgia-and-low-back-pain-are-increasing-a-time-trends-study-using-the-u-s-national-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology